Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...

While Health Technology Assessment agencies anticipate that joint efforts and harmonisation will enhance evaluations’ ...

Inflation, wage growth, and BoJ rate hike bets fuel gains. Can US PMI data shift USD/JPY direction? Key levels in focus.

Gilead Sciences, Inc. today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis (PBC) in ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best ...

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...

A new global guideline for the diagnosis and treatment of Candida infections was recently published in Lancet Infectious ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

EUR/USD edges slightly higher as the US Dollar declines, with investors seeming less fearful about President Trump’s tariff ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.